171 related articles for article (PubMed ID: 20530438)
21. Expression analysis of CD24 and CD44 transcripts in Iranian breast cancer patients.
Liaghati P; Momeni P; Esfandi F; Kholghi Oskooei V; Sattari A; Ghafouri-Fard S; Taheri M
Breast Dis; 2020; 39(3-4):143-148. PubMed ID: 33427725
[TBL] [Abstract][Full Text] [Related]
22. HER2 polymorphisms and breast cancer in Tunisian women.
Kallel I; Kharrat N; Al-fadhly S; Rebai M; Khabir A; Boudawara TS; Rebaï A
Genet Test Mol Biomarkers; 2010 Feb; 14(1):29-35. PubMed ID: 19929405
[TBL] [Abstract][Full Text] [Related]
23.
Pan X; Li M; Huang L; Mo D; Liang Y; Huang Z; Zhu B; Fang M
Biomed Res Int; 2020; 2020():2918517. PubMed ID: 33062675
[TBL] [Abstract][Full Text] [Related]
24. The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients.
Giatromanolaki A; Sivridis E; Fiska A; Koukourakis MI
Med Oncol; 2011 Sep; 28(3):745-52. PubMed ID: 20405247
[TBL] [Abstract][Full Text] [Related]
25. Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters.
Regidor PA; Callies R; Regidor M; Günthert U; Zöller M; Schindler AE
Arch Gynecol Obstet; 1996; 258(3):125-35. PubMed ID: 8781700
[TBL] [Abstract][Full Text] [Related]
26. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
[TBL] [Abstract][Full Text] [Related]
27. Fine-mapping of the 6q25 locus identifies a novel SNP associated with breast cancer risk in African-American women.
Ruiz-Narváez EA; Rosenberg L; Yao S; Rotimi CN; Cupples AL; Bandera EV; Ambrosone CB; Adams-Campbell LL; Palmer JR
Carcinogenesis; 2013 Feb; 34(2):287-91. PubMed ID: 23104177
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women.
Ruiz-Narváez EA; Rosenberg L; Cozier YC; Cupples LA; Adams-Campbell LL; Palmer JR
Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1320-7. PubMed ID: 20406955
[TBL] [Abstract][Full Text] [Related]
29. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.
Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T
Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795
[TBL] [Abstract][Full Text] [Related]
30. Single nucleotide variants in metastasis-related genes are associated with breast cancer risk, by lymph node involvement and estrogen receptor status, in women with European and African ancestry.
Roberts MR; Sucheston-Campbell LE; Zirpoli GR; Higgins M; Freudenheim JL; Bandera EV; Ambrosone CB; Yao S
Mol Carcinog; 2017 Mar; 56(3):1000-1009. PubMed ID: 27597141
[TBL] [Abstract][Full Text] [Related]
31. DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration.
Iida J; Clancy R; Dorchak J; Somiari RI; Somiari S; Cutler ML; Mural RJ; Shriver CD
PLoS One; 2014; 9(2):e88712. PubMed ID: 24586375
[TBL] [Abstract][Full Text] [Related]
32. High TFAP2C/low CD44 expression is associated with an increased rate of pathologic complete response following neoadjuvant chemotherapy in breast cancer.
Spanheimer PM; Askeland RW; Kulak MV; Wu T; Weigel RJ
J Surg Res; 2013 Sep; 184(1):519-25. PubMed ID: 23764310
[TBL] [Abstract][Full Text] [Related]
33. Soluble CD44 splice variants in metastasizing human breast cancer.
Martin S; Jansen F; Bokelmann J; Kolb H
Int J Cancer; 1997 Aug; 74(4):443-5. PubMed ID: 9291436
[TBL] [Abstract][Full Text] [Related]
34. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
35. The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Honeth G; Bendahl PO; Ringnér M; Saal LH; Gruvberger-Saal SK; Lövgren K; Grabau D; Fernö M; Borg A; Hegardt C
Breast Cancer Res; 2008; 10(3):R53. PubMed ID: 18559090
[TBL] [Abstract][Full Text] [Related]
36. ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype.
Zhong Y; Shen S; Zhou Y; Mao F; Guan J; Lin Y; Xu Y; Sun Q
Med Oncol; 2014 Mar; 31(3):864. PubMed ID: 24519209
[TBL] [Abstract][Full Text] [Related]
37. CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma.
Stracquadanio G; Vrugt B; Flury R; Schraml P; Würl P; Müller TH; Knippschild U; Henne-Bruns D; Breitenstein S; Clavien PA; Graf R; Bond GL; Grochola LF
Clin Cancer Res; 2016 Dec; 22(24):6069-6077. PubMed ID: 27283965
[TBL] [Abstract][Full Text] [Related]
38. CD44 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan.
Chou YE; Hsieh MJ; Hsin CH; Chiang WL; Lai YC; Lee YH; Huang SC; Yang SF; Lin CW
PLoS One; 2014; 9(4):e93692. PubMed ID: 24699672
[TBL] [Abstract][Full Text] [Related]
39. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.
Fang XJ; Jiang H; Zhao XP; Jiang WM
BMC Cancer; 2011 Jul; 11():290. PubMed ID: 21749678
[TBL] [Abstract][Full Text] [Related]
40. Quantitative assessment of CD44 genetic variants and cancer susceptibility in Asians: a meta-analysis.
Chandra V; Lee YM; Gupta U; Mittal B; Kim JJ; Rai R
Oncotarget; 2016 Nov; 7(45):74286-74302. PubMed ID: 27521214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]